Apple weighs CXMT memory chips for China-bound iPhones and MacBooks as component crunch meets regulatory hurdles, report says

Apple is testing memory chips produced by China’s CXMT for use in iPhones and MacBooks that would be sold in China, according to a market report published by Quartz (Yahoo Finance). The move, the report said, comes as the industry faces an AI-related component shortage and as Apple navigates U.S. export and technology restrictions that can apply to China supply chains.

The report also said Apple is seeking White House approval to use the CXMT chips in those devices. That suggests the challenge is not only engineering and performance validation, but also whether Apple can obtain the necessary clearance to import or use the component under U.S. rules tied to national security and advanced-technology transfers.

For Apple, memory is a core building block in modern devices. Random-access memory (RAM) and other storage-related components determine how efficiently a phone or laptop can run complex applications and on-device tasks, including functions marketed around AI features. When upstream components become harder to source or comply with regulation, companies often adjust vendors and supply routes to keep production schedules intact.

The article’s framing points to a broader industry pressure: demand for AI-capable hardware has increased the urgency of securing semiconductors and related components. Apple’s response, if it proceeds, would represent a supplier switch at the component level rather than a product redesign, but it can still be complex because Apple’s device performance, power use, and reliability depend on how particular chips integrate with its hardware and software stack.

Even if Apple can validate the CXMT memory chips technically, regulatory approval is likely to determine whether the devices can be built with those parts. The report’s emphasis on White House approval indicates that the timing of clearances could become a gating factor for any switch from testing into large-scale shipments for the China market.

Apple typically addresses supply constraints through a combination of multi-sourcing, inventory planning, and vendor qualification. Still, the specific mention of U.S. executive-level approval underscores that not all supply fixes are simply commercial. Some constraints, particularly those involving advanced-technology export controls or national-security review, can require formal authorization and can take time.

The company did not provide additional detail in the cited post beyond the report’s claims about testing and approval seeking, and the reporting does not outline the exact chip category, the intended Apple device models, or whether any approvals have already been granted. It also does not describe whether Apple is considering CXMT as a primary supplier, a secondary source, or a targeted fallback for particular production runs.

What to watch next is whether Apple announces any China-related component supply updates, whether U.S. agencies publish guidance or clearances that align with the reported request, and whether other device makers in China announce similar vendor changes for memory components tied to AI production demand. If approvals remain uncertain, companies sometimes delay shipments or redesign around alternate suppliers, which can affect device availability and production timing in the near term.